La Trobe

Genetic Bias, Diversity Indices, Physiochemical Properties and CDR3 Motifs Divide Auto-Reactive from Allo-Reactive T-Cell Repertoires

journal contribution
posted on 2025-02-19, 22:56 authored by Oscar L. Haigh, Emma GrantEmma Grant, THO Nguyen, K Kedzierska, MA Field, JJ Miles
The distinct properties of allo-reactive T-cell repertoires are not well understood. To investigate whether auto-reactive and allo-reactive T-cell repertoires encoded distinct properties, we used dextramer enumeration, enrichment, single-cell T-cell receptor (TCR) sequencing and multiparameter analysis. We found auto-reactive and allo-reactive T-cells differed in mean ex vivo frequency which was antigen dependent. Allo-reactive T-cells showed clear differences in TCR architecture, with enriched usage of specific T-cell receptor variable (TRBJ) genes and broader use of T-cell receptor variable joining (TRBJ) genes. Auto-reactive T-cell repertoires exhibited complementary determining regions three (CDR3) lengths using a Gaussian distribution whereas allo-reactive T-cell repertoires exhibited distorted patterns in CDR3 length. CDR3 loops from allo-reactive T-cells showed distinct physical-chemical properties, tending to encode loops that were more acidic in charge. Allo-reactive T-cell repertoires differed in diversity metrics, tending to show increased overall diversity and increased homogeneity between repertoires. Motif analysis of CDR3 loops showed allo-reactive T-cell repertoires differed in motif preference which included broader motif use. Collectively, these data conclude that allo-reactive T-cell repertoires are indeed different to auto-reactive repertoires and provide tangible metrics for further investigations and validation. Given that the antigens studied here are overexpressed on multiple cancers and that allo-reactive TCRs often show increased ligand affinity, this new TCR bank also has translational potential for adoptive cell therapy, soluble TCR-based therapy and rational TCR design.

Funding

This project was supported by the Prostate Cancer Foundation Australia (PCFA) Research Grant (NCG 3913). E.J.G. was supported by a National and Medical Research Council of Australia (NHMRC) C.J Martin Fellowship (1110429) and an Australian Research Council DECRA Fellowship (DE210101479), K.K. is supported by an NHMRC Leadership Investigator Grant (1173871), M.A.F. is supported by National and Medical Research Council of Australia (NHMRC) fellowship (5121190) and J.J.M. was supported by CDF Level 1 & 2 NHMRC Fellowships (1031652 & 1131732).

History

Publication Date

2021-02-05

Journal

International Journal of Molecular Sciences

Volume

22

Issue

4

Article Number

1625

Pagination

16p.

Publisher

MDPI

ISSN

1661-6596

Rights Statement

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Usage metrics

    Journal Articles

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC